14 June 2022 | News
Passive cooling technology will help to retain temperatures from -80 to 25 degrees celsius for up to five days
Image credit: Prnewswire
Etihad Cargo, the cargo and logistics arm of Etihad Aviation Group, has entered into a memorandum of understanding (MoU) with Luxembourg-based B Medical Systems to develop and launch an airline-specific passive temperature-controlled solution for the transportation of life-saving drugs, vaccines and high-value pharmaceuticals.
Sustainable temperature-controlled container units will be developed that utilise passive cooling technology to retain temperatures from -80 to 25 degrees Celsius for up to five days without requiring an external power source, thereby reducing carbon emissions, with load capabilities ranging from two to 1,500 litres. The containers' robust design and multi-use capabilities enable an operational life of over ten years.
Image caption: Dr Omar Najim, Manager Executive Affairs Office at DoH, Andrea Scammacca, COO, B Medical, Jesal Doshi, CEO, B Medical, Abdullah bin Mohammed Al Hamed, Chairman of Department of Health, Dr Nadia Al Bastaki, Chief HROD, Etihad Aviation Group, Tim Isik, VP, Etihad Cargo, Lubna AlLaham, Marketing & Communications, Etihad Cargo, Fabrice Panza, Cool Chain Products, Etihad Cargo